sumatriptan and naproxen sodium tablet, film coated
innovida phamaceutique corporation - sumatriptan succinate (unii: j8bdz68989) (sumatriptan - unii:8r78f6l9vo), naproxen sodium (unii: 9tn87s3a3c) (naproxen - unii:57y76r9atq) - sumatriptan and naproxen sodium tablets are indicated for the acute treatment of migraine with or without aura in adults and pediatric patients 12 years of age and older. limitations of use: - use only if a clear diagnosis of migraine headache has been established. if a patient has no response to the first migraine attack treated with sumatriptan and naproxen sodium tablets, reconsider the diagnosis of migraine before sumatriptan and naproxen sodium tablets are administered to treat any subsequent attacks. - sumatriptan and naproxen sodium tablets are not indicated for the prevention of migraine attacks. - safety and effectiveness of sumatriptan and naproxen sodium tablets have not been established for cluster headache. sumatriptan and naproxen sodium tablets are contraindicated in the following patients: - ischemic coronary artery disease (cad) (angina pectoris, history of myocardial infarction, or documented silent ischemia) or coronary artery vasospasm, including prinzmetal’s angina [see warnings and preca
apo-gabapentin
apotex nz ltd - gabapentin 800mg; - film coated tablet - 800 mg - active: gabapentin 800mg excipient: copovidone hyprolose hypromellose macrogol 8000 magnesium stearate titanium dioxide - gabapentin is indicated for the treatment of neuropathic pain in adults over 18 years of age
apo-gabapentin gabapentin 800mg tablets bottle
arrotex pharmaceuticals pty ltd - gabapentin, quantity: 800 mg - tablet, film coated - excipient ingredients: copovidone; magnesium stearate; titanium dioxide; hypromellose; macrogol 8000; hyprolose - gabapentin is indicated for the treatment of partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs. gabapentin is indicated for the treatment of neuropathic pain.
prezista
janssen-cilag (new zealand) ltd - darunavir ethanolate 867.28mg equivalent to darunavir 800 mg - film coated tablet - 800 mg - active: darunavir ethanolate 867.28mg equivalent to darunavir 800 mg excipient: colloidal silicon dioxide crospovidone hypromellose magnesium stearate opadry red 85f150004 purified water silicified microcrystalline cellulose - adult patients: prezista (with low dose ritonavir as a pharmacokinetic enhancer) is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adult patients.
prezista darunavir 800 mg tablet bottle
janssen-cilag pty ltd - darunavir, quantity: 800 mg - tablet, film coated - excipient ingredients: magnesium stearate; crospovidone; colloidal anhydrous silica; microcrystalline cellulose; hypromellose; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350 - adult patients,prezista ( with low dose ritonavir as a pharmacokinetic enhancer) is indicated in combination with other antiretroviral agents, for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adult patients.,paediatric patients,prezista (with low dose ritonavir as a pharmacokinetic enhancer) is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (hiv) infection in treatment-experienced paediatric patients aged 6 years and older, weighing at least 20 kg.
neurontin
pharmacy retailing (nz) ltd t/a healthcare logistics - gabapentin 800mg; gabapentin 800mg - film coated tablet - 800 mg - active: gabapentin 800mg excipient: candelilla wax crospovidone magnesium stearate maize starch nitrogen opacode orange ns-78-13026 opadry white ys-1-18111 poloxamer 407 purified water active: gabapentin 800mg excipient: candelilla wax crospovidone magnesium stearate maize starch nitrogen opadry white ys-1-18111 poloxamer 407 purified water - neurontin is indicated for the treatment of partial seizures with or without secondarily generalised tonic-clonic seizures, in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs
renagel
pharmacy retailing (nz) ltd t/a healthcare logistics - sevelamer hydrochloride 800mg; - film coated tablet - 800 mg - active: sevelamer hydrochloride 800mg excipient: colloidal silicon dioxide purified water stearic acid
renagel sevelamer hydrochloride 800 mg tablet bottle
sanofi-aventis australia pty ltd - sevelamer hydrochloride, quantity: 800 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; stearic acid; hypromellose; acetylated monoglycerides; propylene glycol; isopropyl alcohol; purified water; iron oxide black - renagel is indicated for the management of hyperphosphataemia in adult patients with stage 4 and 5 chronic kidney disease.
gabapentin 800mg tablets
milpharm ltd - gabapentin - oral tablet - 800mg
gabapentin 800mg tablets
brown & burk uk ltd - gabapentin - oral tablet - 800mg